Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zohara Sternberg

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cardiovascular Therapeutics|October 15, 2013
Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosisZohara Sternberg, Christopher Leung, Daniel Sternberg, et al.
Journal of Neuroimmunology|July 28, 2014
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosisZohara Sternberg, Daniel Sternberg, Allison Drake, et al.
Phlebology|November 21, 2013
Blood pressure normalization post-jugular venous balloon angioplastyZohara Sternberg, Prabhjot Grewal, Steven Cen, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patientsZohara Sternberg, Christopher Leung, Daniel Sternberg, et al.
Journal of Neuroinflammation|October 15, 2009
Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-betaZohara Sternberg, Kailash Chadha, Alicia Lieberman, et al.
Atherosclerosis|November 26, 2013
Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjectsZohara Sternberg, Trevor Chichelli, Daniel Sternberg, et al.
Immunobiology|September 19, 2015
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progressionZohara Sternberg, Anne Chiotti, Joseph Tario, et al.
Journal of Neuroinflammation|November 2, 2010
Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisZohara Sternberg, Cassandra Hennies, Daniel Sternberg, et al.
Immunologic Research|June 24, 2015
High-mobility group box 1 in multiple sclerosisZohara Sternberg, Daniel Sternberg, Trevor Chichelli, et al.
Neuropharmacology|December 4, 2017
Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patientsZohara Sternberg, Channa Kolb, Kailash Chadha, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cardiovascular Therapeutics|October 15, 2013
Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosisZohara Sternberg, Christopher Leung, Daniel Sternberg, et al.
Journal of Neuroimmunology|July 28, 2014
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosisZohara Sternberg, Daniel Sternberg, Allison Drake, et al.
Phlebology|November 21, 2013
Blood pressure normalization post-jugular venous balloon angioplastyZohara Sternberg, Prabhjot Grewal, Steven Cen, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patientsZohara Sternberg, Christopher Leung, Daniel Sternberg, et al.
Journal of Neuroinflammation|October 15, 2009
Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-betaZohara Sternberg, Kailash Chadha, Alicia Lieberman, et al.
Atherosclerosis|November 26, 2013
Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjectsZohara Sternberg, Trevor Chichelli, Daniel Sternberg, et al.
Immunobiology|September 19, 2015
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progressionZohara Sternberg, Anne Chiotti, Joseph Tario, et al.
Journal of Neuroinflammation|November 2, 2010
Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisZohara Sternberg, Cassandra Hennies, Daniel Sternberg, et al.
Immunologic Research|June 24, 2015
High-mobility group box 1 in multiple sclerosisZohara Sternberg, Daniel Sternberg, Trevor Chichelli, et al.
Neuropharmacology|December 4, 2017
Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patientsZohara Sternberg, Channa Kolb, Kailash Chadha, et al.
Pageof 3